Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
-
Alerus Financial Corporation Declares Cash Dividend on Common Shares
-
SHARC Energy Oversubscribes Closing of Third Tranche of Debenture Exercising 25% Overallotment
-
420 with CNW — New York Cannabis Social Equity Entrepreneurs Stuck As State Support Underwhelms
-
Coeur to Participate in the Raymond James London Silver Conference
-
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Cottonwood Psychiatry Expands Telehealth Access to 20 States, Bringing Board-Certified Psychiatric Care to Patients Nationwide
-
Gray & Sons Jewelers Celebrates 46 Years as Miami's Premier Independent Pre-Owned Luxury Watch Dealer
-
Gray & Sons Jewelers Celebrates 46 Years as Miami's Premier Independent Pre-Owned Luxury Watch Dealer
-
Metalsource Mining Grants RSUs And Stock Options
-
Helix BioPharma Corp. Announces Grant and Cancellation of Stock Options
-
Copper Prices Near Record Levels as Sulfur Shortage Bites
-
Health Care Affordability Crisis Creates Momentum for Single-Payer System in Massachusetts
-
BYD Could Take Over European Factories of Legacy Automakers
-
Canadian Gold Resources Announces Non-Brokered LIFE Offering
-
Sierra Madre Receives Mexican Antitrust Approval for the Acquisition of the Del Toro Mine
-
Dogeball vs AlphaPepe: Meme Buyers Shift Toward AlphaPepe as AlphaSwap Offers the Stronger Use Case
-
420 with CNW — Virginia Governor Signs Bill on Cannabis Resentencing
-
Trump’s China Trip Ends Without Breakthroughs on AI, Taiwan or Iran
-
Apogee Acquisition Corp Announces the Separate Trading of Its Class A Ordinary Shares, Warrants and Rights, Commencing on May 28, 2026
-
GigCapital7 Announces Closing of Business Combination with Hadron Energy
-
SCYNEXIS Announces One-for-Eight Reverse Stock Split
-
Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in April
-
Angel Oak Financial Strategies Income Term Trust Issues Mandatorily Redeemable Preferred Shares and New Notes and Sets Record Date and Date for Annual Meeting of Shareholders
-
PHINIA Board Declares Quarterly Dividend of $0.30 per Common Share
-
OceanPal Inc. Receives Nasdaq Notification Regarding Late Filing of Form 20-F
-
ACP Holdings Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about May 28, 2026
-
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
-
Empro Group Inc. Announces Receipt of Delinquency Notification from Nasdaq
-
Terra Innovatum Provides Update on Form 10-K and First Quarter 2026 Reporting Timeline
-
Japan Smaller Capitalization Fund, Inc. Announces Commencement of Tender Offer and Re-Leveling of Level Distribution Plan
-
Inocras Announces ASCO 2026 Online Publication: Whole-genome HRD phenotyping as a predictor of PARP inhibitor benefit in first-line maintenance high-grade serous ovarian cancer
-
Missouri River Water Trail Expands Its Experiences and Outdoor Adventure Services Across Missouri
-
Align Technology Expands Global Operations With Plans for New Multi-Million Dollar Manufacturing Facility in Hyderabad, India
-
Mission Produce and Calavo Growers Merger Obtains Mexican Antitrust Approval
-
XTL Announces Receipt of Staff Delist Determination from Nasdaq
-
Orange County Bancorp, Inc. Declares Cash Dividend
-
Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
-
AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
-
AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
-
ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES
-
Lodestar Announces Adoption of Semi-Annual Reporting
-
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients
-
Flex to Participate in Upcoming Investor Conferences
-
Palladyne AI Announces Employee Equity Awards
-
ContextLogic Holdings Inc. Publishes Q&A Following First Quarter 2026 Results
-
RCI Receives Anticipated Nasdaq Letter Related to 2Q26 10-Q
-
CoreWeave to Participate in the Jefferies Software, Internet, and AI Conference
-
Domo Updates Timing of First Quarter Fiscal 2027 Earnings Conference Call

